Skip NavigationSkip to Content

Familial renal carcinoma: Clinical evaluation, clinical subtypes and risk of renal carcinoma development

  1. Author:
    Zbar, B.
    Glenn, G.
    Merino, M.
    Middelton, L.
    Peterson, J.
    Toro, J.
    Coleman, J.
    Pinto, P.
    Schmidt, L. S.
    Choyke, P.
    Linehan, W. M.
  2. Author Address

    NCI, Urol Oncol Branch, CRC, Bethesda, MD 20892 USA. NCI, Immunobiol Lab, Bethesda, MD 20892 USA. NCI, Pathol Lab, Bethesda, MD 20892 USA. NCI, Mol Imaging Program, Bethesda, MD 20892 USA. NCI, Canc Res Ctr, Bethesda, MD 20892 USA. NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA. SAIC Frederick, Basic Res Program, Frederick, MD USA.;Zbar, B, NCI, Urol Oncol Branch, CRC, 10 Ctr Dr,MSC 1107,Bldg 10,Room 1W-5940, Bethesda, MD 20892 USA.;zbarb@ncifcrf.gov
    1. Year: 2007
    2. Date: Feb
  1. Journal: Journal of Urology
    1. 177
    2. 2
    3. Pages: 461-465
  2. Type of Article: Article
  3. ISSN: 0022-5347
  1. Abstract:

    Purpose: Familial renal carcinoma is defined as families with 2 or more individuals with renal cell carcinoma without evidence of known hereditary renal carcinoma syndromes. To better characterize this familial cancer we reviewed renal carcinoma families evaluated at the National Cancer Institute between 1990 and 2004 to identify distinctive features of these families. We also determined the risk of renal carcinoma in first-degree relatives of affected family members. Materials and Methods: We evaluated 141 at risk asymptomatic relatives of affected individuals from 50 families with 2 or more members with renal carcinoma. Histology slides of renal tumors from affected family members were reviewed. At risk members from renal carcinoma families were screened for occult renal neoplasms by renal ultrasound and computerized tomography. DNA from select families was tested for germline mutations of known renal carcinoma genes when clinically indicated and constitutional cytogenetic analysis was performed to search for germline chromosome alterations. Results: Familial renal carcinoma families could be subdivided into subtypes based on tumor multiplicity and renal tumor histology. Of 141 at risk members of renal carcinoma families screened for occult renal tumors 2 were found to have occult renal tumors, which were identified as renal oncocytoma and a solid tumor that was not resected, respectively. No histologically confirmed occult renal carcinomas were detected in at risk family members. Several families previously classified as having familial renal carcinoma were found on further evaluation to have hereditary renal cancer syndromes. Conclusions: Familial renal carcinoma is a heterogeneous clinical and pathological entity. Familial renal carcinoma was subdivided into groups based on tumor multiplicity and tumor pathology. The empirical risk of histologically documented renal carcinoma in first-degree relatives who were members of familial renal carcinoma families was less than 1:141. One renal oncocytoma and 1 small solid renal tumor were detected.

    See More

External Sources

  1. DOI: 10.1016/j.juro.2006.09.037
  2. WOS: 000243453900009

Library Notes

  1. No notes added.

Your Recently Viewed Publications:

Heads or tails: Wnts and anterior-posterior patterning
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel